NCCI edits and MUE limits for nephrology claims.
Nephrology's bundling denials cluster around pairs that don't show up in general billing content: a renal biopsy against its own imaging guidance, a dialysis drug that isn't bundled by NCCI at all but by an entirely different payment mechanism, and a monthly capitation code that carries a different unit cap depending on which of three separate CMS tables the claim runs through. This guide is the procedure-family reference our nephrology billing and coding guide points to — the specific pairs, indicators, and the one distinction — three MUE tables, not one — that most nephrology billing content skips entirely.
Key takeaways
- MUE caps live in three separate CMS tables — Practitioner Services, Facility Outpatient (Hospital), and DME Supplier — and the same code can carry a different unit limit in each. A dialysis facility's institutional claim and the nephrologist's professional claim for related codes run through different tables entirely.
- Renal biopsy (50200) and its imaging guidance codes are a genuine NCCI pair, with a modifier indicator of 1 — the override exists but is narrow, and routine use invites audit.
- ESA and dialysis-drug bundling isn't an NCCI edit at all. It's ESRD Consolidated Billing folded into the per-treatment payment — a different mechanism, with no modifier override, and confusing the two wastes an appeal on a claim that was never appealable that way.
- The MCP-versus-session dialysis code conflict is a code-family selection error, not a bundling edit — no indicator value makes billing both correct for the same patient's related care in the same month.
Three MUE tables, not one
CMS publishes Medically Unlikely Edit values in three separate files, revised on the same quarterly cadence as the NCCI PTP edit file: Practitioner Services, Facility Outpatient (Hospital) Services, and DME Supplier Services. Each table sets its own unit cap per code per date of service, and the same CPT code doesn't necessarily carry the same number across all three — a code can be capped tighter on the facility side than the practitioner side, or vice versa, because the two tables model plausibility against different billing contexts.
This isn't a technicality in nephrology; it's the normal claim pattern. An ESRD facility bills its per-treatment or per-month charges on an institutional claim that runs against the Facility Outpatient table. A nephrologist billing the professional component of the same patient's monthly management, or a same-day E/M, runs against the Practitioner table. A vascular access procedure performed in a hospital outpatient department generates two claims — the facility's and the physician's — that can hit different MUE ceilings for related codes on the same date of service. Pulling a cap from one table and assuming it governs the other claim type is a common, avoidable confusion point when a billing office and a facility compare notes on why a claim capped differently than expected.
Effective dates follow the standard NCCI/MUE release rhythm — quarterly, with each quarter's file typically posted roughly a month ahead of its effective date (the July 1 file, for example, posts around June 1). ⚠️ This build corroborated the three-table structure and the general quarterly release cadence against CMS's own MUE program page and multiple independent secondary coding sources, but did not pull the current quarter's specific unit-cap values for individual nephrology codes directly from CMS's MUE files this session, since CMS.gov's own downloadable files returned an access error to automated fetch. Look up the current cap for any specific code, in the specific table matching your claim type, at the CMS Medically Unlikely Edits page before building a denial-avoidance rule around a specific number.
Procedure-family bundling reference
The pairs below are the ones that actually generate nephrology bundling denials, organized by the mechanism behind each — because "it's bundled" covers at least three genuinely different systems in this specialty, and the override path (if one exists) depends entirely on which one applies.
| Codes | Mechanism | Override path |
|---|---|---|
| ESRD MCP (90951–90970) vs. session-based dialysis (90935–90947) | Payment-model exclusivity for the same patient's related care in the same month | None — select the correct code family for the clinical population, not a modifier |
| 36901 (diagnostic access study) vs. 36902–36906 (escalated intervention) | Included work, built into the escalated code's own descriptor | None — bill only the single highest-level code performed on that circuit that session |
| 36907–36909 (central-segment add-ons) vs. primary access code | Add-on codes, each with its own MUE cap | Report only for genuinely distinct central-segment work, documented separately from the peripheral intervention |
| 50200 (percutaneous renal biopsy) vs. 76942/77001/77012/77021 (imaging guidance) | NCCI PTP edit, modifier indicator 1 | 59/X-modifier only where the record shows imaging beyond routine procedural guidance — ⚠️ see sourcing note below |
| Dialysis-related drugs (ESAs, IV iron, vitamin D analogs) vs. the ESRD per-treatment payment | ESRD Consolidated Billing — a benefit-bundling rule, not an NCCI PTP edit | None for an in-center maintenance patient's related care — not a Column 1/2 pair a modifier touches |
| E/M vs. same-day vascular access procedure (typically 0-day global) | Global-surgery bundling, governed by modifier 25 documentation standards, not a classic PTP pair | 25, only where the note independently supports a significant, separately identifiable service |
The renal biopsy pair is worth stating precisely, because it's absent from most nephrology billing content entirely. Industry coding sources describe CPT 50200 as bundled under NCCI against the common guidance codes — 76942 (ultrasound guidance), and the fluoroscopic/CT-guidance family (77001, 77012, 77021) — with a modifier indicator of 1, meaning an override is theoretically possible but narrow. The clinical rationale CMS has cited for the edit is that imaging guidance is integral to a safe percutaneous biopsy, not a separately identifiable service by default. ⚠️ This pairing is corroborated across coding-industry secondary sources (AAPC coding alerts and reference tools) rather than confirmed directly against the current NCCI PTP edit file this session, and at least one of these sources notes the edit's history includes a prior deletion-and-reinstatement cycle — confirm the current quarter's status for this specific pair in the CMS NCCI PTP Edits Lookup Tool before building a scrubber rule on it.
ESRD Consolidated Billing is the mechanism nephrology billers most often mistake for an NCCI edit, and the distinction matters because the remedy is completely different. Erythropoiesis-stimulating agents, IV iron, vitamin D analogs, and most other dialysis-related drugs and lab tests that were separately billable under Part B before 2011 were folded into the ESRD Prospective Payment System's per-treatment bundled payment for facility claims. That's not a Column 1/Column 2 code pair with a modifier indicator attached to it — it's a benefit-category rule that removes the drug from separate Part B payment for an in-center maintenance patient's related care entirely. A denial built on this basis doesn't get fixed with 59 or an X-modifier, because the drug claim was never eligible for separate payment in that context to begin with; the facility bills it as part of the case-mix adjusted composite rate instead.
Before writing any nephrology bundling appeal, name the mechanism first: NCCI PTP edit, MUE cap, ESRD Consolidated Billing, or global-surgery/modifier-25. Each has a different override path, and a denial-management team that defaults to "append 59 and resubmit" for all four will win the NCCI cases occasionally, lose the consolidated-billing cases every time, and burn staff hours on appeals that were never structurally possible.
Do and don't
- Check the MUE table matching the actual claim type — Practitioner, Facility Outpatient, or DME — not whichever table you last looked at.
- Name the bundling mechanism (PTP edit, MUE, consolidated billing, global period) before deciding whether a modifier can even apply.
- Document a genuinely separate diagnostic need before appending 59 or an X-modifier to 50200 alongside its imaging guidance code.
- Re-check the current quarter's file for any pair before relying on last quarter's value.
- Don't apply a Practitioner-table MUE cap to a facility's institutional claim, or the reverse.
- Don't append a modifier to an ESA or dialysis-drug denial expecting it to work like an NCCI override — it's a different mechanism with no modifier path.
- Don't bill 50200 with routine imaging guidance as standing practice without a documented, distinct reason.
- Don't treat the MCP-versus-session dialysis conflict as anything other than a code-family selection error.
Not sure which of your nephrology bundling denials are actually winnable?
We'll check the current NCCI, MUE, and consolidated-billing rules against your denial log and tell you which appeals are worth filing and which claims to write off.
Frequently asked questions
Why does the MUE limit for the same code look different depending on who's billing it?
Because CMS publishes MUE values in three separate tables — Practitioner Services, Facility Outpatient (Hospital) Services, and DME Supplier Services — and the same CPT code can carry a different unit cap in each one. A dialysis facility's institutional claim for a session-based hemodialysis code runs against the Facility Outpatient table, while a nephrologist's professional-service claim for the same code runs against the Practitioner table. Pulling a cap from the wrong table and applying it to the other claim type is a common, avoidable source of confusion when a facility and a physician group compare notes on the same denial.
Can we bill an ESA or IV iron separately for an in-center maintenance dialysis patient?
Not under original Medicare, and this isn't an NCCI bundling question at all — it's ESRD Consolidated Billing. Erythropoiesis-stimulating agents, IV iron, vitamin D analogs, and most other dialysis-related drugs were folded into the ESRD Prospective Payment System's per-treatment bundled payment for facility claims starting in 2011, and they aren't separately payable to Part B outside that bundle for an established in-center maintenance patient. Appending a modifier to try to unbundle an ESA claim doesn't work here, because the drug was never a Column 2 code paired against a Column 1 procedure — it's excluded from separate billing by the payment system itself.
Is imaging guidance ever separately billable with a percutaneous renal biopsy?
Rarely, and only with documentation that goes beyond routine procedural guidance. CPT 50200 carries an NCCI edit against the common guidance codes (76942 ultrasound guidance, and the fluoroscopic/CT guidance family) with a modifier indicator of 1, meaning an override is theoretically possible but requires the record to show the imaging was a genuinely separate, distinctly medically necessary study — not the guidance CMS already considers integral to a safe percutaneous biopsy. Routine use of a 59 or X-modifier here without that distinction is exactly the audit-prone pattern payers watch for.
Verify before billing. CPT is a registered trademark of the American Medical Association; codes here are paraphrased, not reproduced from the CPT Professional edition. CPT, HCPCS and ICD-10 codes, coverage policy, and bundling edits change, including annual code-set updates. This page reflects standard industry practice and is provided for general education — it is not a substitute for your own compliance review, your current payer contracts, or the current-year code sets. Confirm requirements against your specific payer mix before submitting claims.